Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 369 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Φίλτρα: Συντάκτης is Polyzos, Stergios A  [Clear All Filters]
Journal Article
Anastasilakis, A. D., Polyzos S. A., Kitridis D., Makras P., Yavropoulou M. P., Palermo A., et al. (2021).  Ιrisin levels in postmenopausal women with an incident hip fracture.. Endocrine. 73(3), 719-722.
Anastasilakis, A. D., Papapoulos S. E., Polyzos S. A., Appelman-Dijkstra N. M., & Makras P. (2019).  Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial.. J Bone Miner Res.
Polyzos, S. A., Kountouras J., Anastasilakis A. D., & Terpos E. (2023).  Wnt/beta-catenin signaling inhibitors and nonalcoholic fatty liver disease: Potential therapeutic implications.. Hepatobiliary Pancreat Dis Int.
Doulberis, M., Papaefthymiou A., Kountouras J., Polyzos S. A., Srivastava S., Klokowska-Röetzler J., et al. (2019).  Vitamin D Deficiency and Unclear Abdominal Pain in Patients from Low- and Middle-Income Countries.. Int J Environ Res Public Health. 16(23), 
Polyzos, S. A., & Kountouras J. (2012).  Visual vignette. Anaplastic thyroid carcinoma.. Endocr Pract. 18(1), 108.
Polyzos, S. A., Kountouras J., Polymerou V., Papadimitriou K. G., Zavos C., & Katsinelos P. (2016).   Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patients with nonalcoholic fatty liver disease.. Ann Hepatol. 15(5), 705-14.
Polyzos, S. A., & Mantzoros C. S. (2015).  An update on the validity of irisin assays and the link between irisin and hepatic metabolism.. Metabolism. 64(9), 937-42.
Doulberis, M., Papaefthymiou A., Srivastava D. S., Exadaktylos A. K., Katsinelos P., Kountouras J., et al. (2020).  Update on the association between non-alcoholic fatty liver disease and Helicobacter pylori infection.. Int J Clin Pract. e13737.
Vachliotis, I. D., Valsamidis I., & Polyzos S. A. (2023).  Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma.. Cancers (Basel). 15(21), 
Kountouras, J., Gavalas E., Papaefthymiou A., Tsechelidis I., Polyzos S. A., Bor S., et al. (2020).  Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial.. Medicina (Kaunas). 56(7), 
Boziki, M., Grigoriadis N., Papaefthymiou A., Doulberis M., Polyzos S. A., Gavalas E., et al. (2021).  The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis.. Neurochem Int. 144, 104938.
Polyzos, S. A., & Goulas A. (2020).  Treatment of nonalcoholic fatty liver disease with an anti-osteoporotic medication: A hypothesis on drug repurposing.. Med Hypotheses. 110379.
Doulberis, M., Polyzos S. A., Papaefthymiou A., Katsinelos P., Kiosses C., & Kountouras J. (2020).  Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents.. Expert Opin Pharmacother. 21(3), 247-251.
Polyzos, S. A., Anastasilakis A. D., & Terpos E. (2009).  Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid.. Support Care Cancer. 17(10), 1329-30.
Polyzos, S. A., Goulas A., & Papaioannidou P. (2023).  Tirzepatide for Diabetes and Obesity: A New Window to the Treatment of Non-alcoholic Steatohepatitis.. Curr Med Chem.
Toulis, K. A., Goulis D. G., Tsolakidou K., Hilidis I., Fragkos M., Polyzos S. A., et al. (2013).  Thyrotropin receptor autoantibodies and early miscarriages in patients with Hashimoto thyroiditis: a case-control study.. Gynecol Endocrinol. 29(8), 793-6.
Polyzos, S. A., Kita M., & Avramidis A. (2007).  Thyroid nodules - stepwise diagnosis and management.. Hormones (Athens). 6(2), 101-19.
Efstathiadou, Z. A., Kita M. D., & Polyzos S. A. (2018).  Thyroid dysfunction and non-alcoholic fatty liver disease.. Minerva Endocrinol. 43(3), 367-376.
Makras, P., Papapoulos S. E., Polyzos S. A., Appelman-Dijkstra N. M., & Anastasilakis A. D. (2020).  The three-year effect of a single zoledronate infusion on bone mineral density and bone turnover markers following denosumab discontinuation in women with postmenopausal osteoporosis.. Bone. 138, 115478.
Anastasilakis, A. D., Polyzos S. A., & Makras P. (2018).  THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis.. Eur J Endocrinol. 179(1), R31-R45.
Toulis, K. A., Anastasilakis A. D., Polyzos S. A., & Makras P. (2011).  Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis.. Hormones (Athens). 10(3), 174-95.
Polyzos, S. A., Perakakis N., Boutari C., Kountouras J., Ghaly W., Anastasilakis A. D., et al. (2019).  Targeted analysis of three hormonal systems identifies molecules associated with the presence and severity of NAFLD.. J Clin Endocrinol Metab.
Polyzos, S. A., & Anastasilakis A. D. (2010).  A systematic review of cases reporting needle tract seeding following thyroid fine needle biopsy.. World J Surg. 34(4), 844-51.
Polyzos, S. A., & Anastasilakis A. D. (2010).  Systematic review of cases reporting blood extravasation-related complications after thyroid fine-needle biopsy.. J Otolaryngol Head Neck Surg. 39(5), 532-41.
Avramidis, A., Polyzos S. A., Efstathiadou Z., & Kita M. (2008).  Sustained clinical inactivity and stabilization of GH/IGF-1 levels in an acromegalic patient after discontinuation of somatostatin analogue treatment.. Endocr J. 55(2), 351-7.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές